Abstract:Background: Benzodiazepines (BZDs) and Z-drugs have been widely used in clinical practice and there have been limited data from large populations about hazardous BZDs and Z-drugs use and its correlates in patients with mental disorder. The study aimed to assess the current status of hazardous BZDs and Z-drugs use and its related factors via analysis of prescriptions in outpatient psychiatric settings in China.Methods: The study included outpatients who were prescribed at least one BZDs or Z-drugs from 5 psychiatric settings in the east, central and west regions of China in 2018. Demographic and prescription information were extracted from the electronic prescription dispensing database. We defined the co-occurence of overdose [>40mg Diazepam Milligram Equivalence (DME)] and long-term use (>consecutive 90 days) as the hazardous hypnotics use, and patients whose recorded diagnoses did not meet any indications in Chinese FDA as the over-indication users. In addition, 200 patients who were detected as hazardous users in one of the hospitals in the east region were randomly selected for follow-up interview to confirm the actual situation.Findings: Among the 720 054 outpatients in 2018, 164 450 (22·8%) patients had at least one BZDs or Z-drugs prescription. Most of the patients were females (63·6%) and were aged 18 to 64 (76·2%). Of the total patients, 55·9% patients were prescribed with over-indication use and 3% were defined as hazardous users. Multivariate logistic regression shown that factors associated with a greater likelihood of hazardous use were older age (aOR[>65]: 5·05; 95%CI: 3·24-8·40), male gender (aOR: 1·20; 95%CI: 1·13-1·28), west region (aOR 1·13; 95%CI: 1·05-1·22), over-indications use (aOR 3·09; 95%CI: 2·82-3·39), a more frequent outpatient visit (aOR 1·06; 95%CI: 1·06-1·07), a greater number of different doctors visits (aOR 1·23; 95%CI: 1·22-1·24), and patients diagnosed particularly as Behavioral syndromes associated with physiological disturbances and physical factors (aOR 3·65; 95%CI:3·07-4·30), Epilepsy and recurrent seizures (aOR 5·22; 95%CI: 4·29-6·30) and Sleep disorders (aOR 1·85; 95%CI: 1·67-2·04). 98·5% (197/200) of patients at hazardous use risk cannot be effectively accessed because they registered the wrong contact information in the outpatient system (72·5%) or refused to be followed up (26%), and one of three patients who completed the interview met the DSM-5 criteria for Sedative hypnotics dependence syndrome.Interpretation: Sedative hypnotic drugs are commonly used clinically, and there are relatively large proportion of over-indication users in outpatients psychiatric settings in China. Whereas, a small proportion of patients at risk of hazardous BZDs and Z-drugs use (long-term and high-dose use) were detected by prescription data. The question raised by this study is how to use prescription data to support improvements in clinical practice.Funding: National Natural Science Foundation of China, Clinical Research Center of Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center Clinical Research Center and Shanghai Municipal Health Commission.Declaration of Interest: None to declare. Ethical Approval: The study was approved and monitored by Shanghai Mental Health Center (permission number: 2019-22)

Consumption patterns and factors associated with inappropriate prescribing of benzodiazepines in Primary Health Care settings

Study on medication prescription in the elderly population: benzodiazepine use and potential drug interactions

Potentially inappropriate use of benzodiazepines and z-drugs in the older population—analysis of associations between long-term use and patient-related factors

Chronic benzodiazepine usage among older people: prevalence, indications, and treatment modifications in patients admitted to an acute geriatric unit

Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries

Role of community pharmacists in the detection of potentially inappropriate benzodiazepines prescriptions for insomnia

As interações medicamentos a de benzodiazepínicos em idosos: revisão integrativa de literatura / Use of benzodiazepinics in the elderly: integrative literature review

[Benzodiazepin addiction: a silent addiction among older people]

Association of Benzodiazepine Prescription With Short‐Term Prognosis in Elderly Patients Attended in Emergency Department: Results From the EDEN PROJECT

Benzodiazepines and risk of dementia – Is there a reason for alarm?

Electrophysiological and Neuropsychological Indices of Cognitive Dysfunction in Patients with Chronic Insomnia and Severe Benzodiazepine Use Disorder

Risk Characterization in Patients Using Benzodiazepines While Providing Pharmaceutical Care Dispensing Service

Hazardous Use of Benzodiazepine and Z-Drugs in Psychiatric Clinics in China: An Electronic Prescription Database Study

Does Physicians' Clinical Competence, Communication Ability, or Cultural Background Influence Potentially Inappropriate Prescribing of Benzodiazepines and Z‐Drugs Among Older Adults With Insomnia?

Use of prescription benzodiazepines and related drugs in family caregivers: a nation-wide register-based study

Long-term use of benzodiazepines in chronic insomnia: a European perspective

Characteristics of high-dose benzodiazepine use: nationwide cohort study on new benzodiazepine users with 5-year follow-up

Factors associated with long-term benzodiazepine and Z-drug use across the lifespan and 5-year temporal trajectories among incident users: a Swedish nationwide register-based study

Patterns of Psychoactive Drug Administration to Nursing Home Residents with Distress Behavior in Dementia (RP116)

Benzodiazepine Use in Opioid Maintenance Treatment Programme: Risks and Clinical Outcomes

P15: Impact of perceived sleep quality and sleep aid use on mortality risk: the Brazilian Longitudinal Study of Aging